CeraVx
Pharmaceutical Manufacturing • 
Leiden, South Holland, Netherlands • 1-10 Employees
Company overview
| Headquarters | Leiden BioScience Park, BioPartner 4, Unit 4358, Robert Boyleweg 4, Leiden, 2333 CG, NL |
| Phone number | +31713322335 |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Keywords | Vaccine Delivery, Infectious Diseases, Therapeutic Vaccines, Dermal Drug Delivery, Prophylactic Vaccines, Leiden Bio Science Park, Skin Patches, Mrna Nano Particles |
| Founded | 2024 |
| Employees | 1-10 |
| Socials |
Key Contact at CeraVx
Dinja Oosterhoff
Director R&D A.I.
About CeraVx
CeraVx B.V. is a privately held global biotechnology company developing and commercializing a proprietary drug delivery platform based on a ceramic micro-needle array patches (CeraMAPs™). The CeraMaps technology was initially developed at the University of Twente, MESA+, Institute for Nanotechnology, The Netherlands. The company is focussing on prophylactic and therapeutic vaccines. In 2024 CeraVx acquired the propietary micro-needle technology from MLT.
CeraVx revenue & valuation
| Annual revenue | $769,995 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $2,500,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
CeraVx has 5 employees across 4 departments.
Departments
Number of employees
Funding Data
CeraVx has never raised funding before.
Israel
United States
Spain
ItalyFrequently asked questions
4.8
40,000 users
